The methylenetetrahydrofolate reductase 677C>T gene polymorphism is not associated with chronic plaque psoriasis

Experimental Dermatology

Volumn 17, Issue 9, 2008, Pages 748-751

  Weger, Wolfgang ^a   Hofer, Angelika ^a   Stanger, Olaf ^b   Wolf, Peter ^a   El Shabrawi, Yosuf ^a   Renner, Wilfried ^a   Kerl, Helmut ^a   Salmhofer, Wolfgang ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b PARACELSUS MEDICAL UNIVERSITY   (Austria)

Author keywords

Chronic plaque psoriasis; Folate; Homocysteine; MTHFR 677C>T gene polymorphism; Vitamin B12

Indexed keywords

CYANOCOBALAMIN; CYTOSINE; FOLIC ACID; HOMOCYSTEINE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); THYMINE;

ADULT; ARTICLE; CAUCASIAN; CHRONIC DISEASE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOMOZYGOSITY; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID BASE SUBSTITUTION; PREVALENCE; PROTEIN BLOOD LEVEL; PSORIASIS VULGARIS;

ADULT; AUSTRIA; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PSORIASIS; VITAMIN B 12;

EID: 49049113307     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2008.00713.x     Document Type: Article

References (27)

1. Baiqiu W, Songbin F, Guiyin Z, Pu L. Study of the relationship between psoriasis and the polymorphic site C677T of the methylenetetrahydrofolate reductase. Chin Med Sci J 2000: 15: 119-120.
2. Kang S S, Wong P W, Bock H G, Horwitz A, Grix A. Intermediate hyperhomocysteinemia resulting from compound heterozygosity of methylenetetrahydrofolate reductase mutations. Am J Hum Genet 1991: 48: 546-551.
3. Selhub J, Miller J W. The pathogenesis of homocysteinemia: Interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine. Am J Clin Nutr 1991: 55: 131-138.
4. Feinberg A P. Methylation meets genomics. Nat Genet 2001: 27: 9-10.
5. Bird A P, Wolffe A P. Methylation-induced repression - belts, braces, and chromatin. Cell 1999: 99: 451-454.
6. Razin A, Riggs A D. DNA methylation and gene function. Science 1980: 210: 604-610.
7. Engbersen A M, Franken D G, Boers G H, Stevens E M, Trijbels F J, Blom H J. Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am J Hum Genet 1995: 56: 142-150.
8. Harmon D L, Woodside J V, Yarnell J W et al. The common thermolabile variant of the methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinemia. QJM 1996: 89: 571-577.
9. Vanizor Kural B, Örem A, Çimşit G, Uydu H A, Yandi Y E, Alver A. Plasma homocysteine and its relationships with atherothrombotic markers in psoriatic patients. Clin Chim Acta 2003: 332: 23-30.
10. Malerba M, Gisondi P, Radaeli A et al. Plasma homocysteine and folate levels in patients with chronic plaque psoriasis. Br J Dermatol 2006: 155: 1165-1169.
11. Fredriksson T, Pettersson U. Severe psoriasis - oral therapy with a new retinoid. Dermatologica 1978: 157: 238-244.
12. Ubbink J B, Hayward-Vermaak W J, Bissbort S. Rapid high-performance liquid chromatography assay for total homocysteine levels in human serum. J Chromatogr 1991: 565: 441-446.
13. Vester B, Rasmussen K. High-performance liquid chromatography for rapid and accurate determination of homocysteine in plasma and serum. Eur J Clin Chem Clin Biochem 1991: 29: 549-554.
14. Stanger O, Hermann W, Pietrzik K et al. DACH-Liga Homocystein (German, Austrian and Swiss Homocysteine Society): Consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: Guidelines and recommendations. Clin Chem Lab Med 2003: 41: 1392-1403.
15. Weger W, Hofer A, Wolf P et al. The angiotensin-converting enzyme insertion/deletion and the endothelin-134 3A/4A gene polymorphisms in patients with chronic plaque psoriasis. Exp Dermatol 2007: 16: 993-998.
16. Seinost G, Renner W, Brodmann M, Winkler M, Köppel H, Pilger E. C677T mutation in the methylene tetrahydrofolate reductase gene as a risk factor for venous thrombotic disease in Austrian patients. Thromb Res 2000: 100: 405-407.
17. Stern L L, Mason J B, Selhub J, Choi S W. Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene. Cancer Epidemiol Biomarkers Prev 2000: 9: 849-853.
18. Ruchusatsawat K, Wongpiyabovorn J, Shuangshoti S, Hirankarn N, Mutirangura A. SHP-1 promoter 2 methylation in normal epithelial tissues and demethylation in psoriasis. J Mol Med 2006: 84: 175-182.
19. Graham I M, Daly L E, Refsum H M et al. Plasma homocysteine as a risk factor for vascular disease: The European Concerted Action Project. JAMA 1997: 277: 1775-1781.
20. Clarke R, Daly L, Robinson K et al. Hyperhomocysteinemia: An independent risk factor for vascular disease. N Engl J Med 1991: 324: 1149-1155.
21. Mallbris L, Akre O, Granath F et al. Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients. Eur J Epidemiol 2004: 19: 225-230.
22. McDonald C J. Cardiovascular disease in psoriasis. J Invest Dermatol 1989: 92: 646-647.
23. Henseler T, Christophers E. Disease concomitance in psoriasis. J Am Acad Dermatol 1995: 32: 982-986.
24. Refsum H, Ueland P M, Nygard O, Vollset S E. Homocysteine and cardiovascular disease. Annu Rev Med 1998: 49: 31-62.
25. Brattström L. Vitamins as homocysteine-lowering agents. J Nutr 1996: 126: 1276S-1280S.
26. Fry L, MacDonald A, Almeyda J, Griffin C J, Hoffbrand A V. The mechanism of folate deficiency in psoriasis. Br J Dermatol 1971: 84: 539-544.
27. Hild D H. Folate losses from the skin of exfoliative dermatitis. Arch Intern Med 1969: 123: 51-57.